| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Prostatic Neoplasms | 23 | 2020 | 1637 | 1.90 | Why? |
| Prostate | 14 | 2019 | 283 | 1.53 | Why? |
| Hyperthermia, Induced | 3 | 2017 | 106 | 1.35 | Why? |
| Antibiotics, Antineoplastic | 2 | 2018 | 128 | 1.32 | Why? |
| Doxorubicin | 3 | 2018 | 313 | 1.32 | Why? |
| Liver Neoplasms | 5 | 2019 | 1666 | 1.05 | Why? |
| Chemoembolization, Therapeutic | 4 | 2019 | 144 | 1.04 | Why? |
| Thorax | 2 | 2021 | 1873 | 0.85 | Why? |
| Clinical Chemistry Tests | 1 | 2021 | 82 | 0.84 | Why? |
| Magnetic Resonance Imaging | 16 | 2020 | 6551 | 0.81 | Why? |
| Image-Guided Biopsy | 12 | 2020 | 185 | 0.81 | Why? |
| Biopsy, Needle | 2 | 2012 | 303 | 0.77 | Why? |
| Surgery, Computer-Assisted | 2 | 2015 | 183 | 0.77 | Why? |
| Ultrasonography, Interventional | 6 | 2019 | 560 | 0.75 | Why? |
| Taxoids | 1 | 2016 | 45 | 0.65 | Why? |
| Tomography, X-Ray Computed | 15 | 2021 | 25144 | 0.64 | Why? |
| Disposable Equipment | 1 | 2020 | 332 | 0.63 | Why? |
| Hematologic Tests | 1 | 2021 | 521 | 0.63 | Why? |
| Magnetic Resonance Imaging, Interventional | 5 | 2020 | 38 | 0.62 | Why? |
| Drug Delivery Systems | 4 | 2018 | 1365 | 0.59 | Why? |
| Cone-Beam Computed Tomography | 1 | 2015 | 118 | 0.55 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.44 | Why? |
| Carcinoma, Hepatocellular | 1 | 2019 | 1222 | 0.37 | Why? |
| Neoplasm Grading | 9 | 2020 | 400 | 0.36 | Why? |
| Glutamate Carboxypeptidase II | 2 | 2017 | 24 | 0.36 | Why? |
| Magnetics | 1 | 2007 | 66 | 0.34 | Why? |
| Neoplasm Recurrence, Local | 1 | 2015 | 1063 | 0.34 | Why? |
| Disease Models, Animal | 5 | 2019 | 10998 | 0.32 | Why? |
| Antigens, Surface | 2 | 2017 | 181 | 0.32 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.32 | Why? |
| Biopsy, Large-Core Needle | 4 | 2018 | 81 | 0.31 | Why? |
| Cysteine | 2 | 2017 | 238 | 0.31 | Why? |
| Diffusion Magnetic Resonance Imaging | 2 | 2018 | 317 | 0.30 | Why? |
| Immunotherapy | 1 | 2019 | 2421 | 0.29 | Why? |
| Liposomes | 2 | 2017 | 334 | 0.28 | Why? |
| Antineoplastic Agents | 2 | 2017 | 3550 | 0.26 | Why? |
| Catheter Ablation | 1 | 2007 | 438 | 0.24 | Why? |
| Ultrasonography | 8 | 2020 | 4409 | 0.24 | Why? |
| Microspheres | 3 | 2018 | 261 | 0.24 | Why? |
| Urinary Bladder Neoplasms | 2 | 2018 | 614 | 0.22 | Why? |
| Prostatectomy | 4 | 2018 | 485 | 0.21 | Why? |
| Drug Liberation | 2 | 2017 | 141 | 0.21 | Why? |
| Watchful Waiting | 2 | 2019 | 276 | 0.20 | Why? |
| Supervised Machine Learning | 1 | 2021 | 172 | 0.19 | Why? |
| Angiography | 1 | 2020 | 301 | 0.18 | Why? |
| Neoplasms, Connective Tissue | 1 | 2017 | 5 | 0.18 | Why? |
| Medical Waste Disposal | 1 | 2020 | 221 | 0.17 | Why? |
| Rabbits | 2 | 2018 | 1171 | 0.17 | Why? |
| Radiology, Interventional | 2 | 2020 | 398 | 0.17 | Why? |
| Tumor Burden | 1 | 2019 | 369 | 0.17 | Why? |
| Camptothecin | 1 | 2017 | 39 | 0.17 | Why? |
| Positron Emission Tomography Computed Tomography | 2 | 2017 | 1458 | 0.17 | Why? |
| Needles | 1 | 2018 | 87 | 0.17 | Why? |
| CTLA-4 Antigen | 1 | 2019 | 282 | 0.17 | Why? |
| Hospital Design and Construction | 1 | 2020 | 287 | 0.17 | Why? |
| Cryosurgery | 1 | 2017 | 57 | 0.17 | Why? |
| Hospitals, Isolation | 1 | 2020 | 300 | 0.16 | Why? |
| Multimodal Imaging | 2 | 2018 | 534 | 0.16 | Why? |
| Urinary Bladder | 1 | 2017 | 170 | 0.15 | Why? |
| Microfluidics | 1 | 2017 | 171 | 0.15 | Why? |
| Prostate-Specific Antigen | 4 | 2018 | 213 | 0.15 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2016 | 274 | 0.15 | Why? |
| Mice, Nude | 1 | 2016 | 340 | 0.15 | Why? |
| Drug Carriers | 2 | 2018 | 590 | 0.14 | Why? |
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 316 | 0.14 | Why? |
| Tissue Distribution | 1 | 2016 | 483 | 0.14 | Why? |
| Prostatic Hyperplasia | 1 | 2016 | 161 | 0.14 | Why? |
| Random Allocation | 1 | 2016 | 773 | 0.13 | Why? |
| Feasibility Studies | 2 | 2020 | 3467 | 0.13 | Why? |
| Equipment and Supplies | 1 | 2018 | 440 | 0.12 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2018 | 436 | 0.12 | Why? |
| Polyethylene Glycols | 1 | 2017 | 574 | 0.12 | Why? |
| Radiopharmaceuticals | 1 | 2017 | 763 | 0.12 | Why? |
| Radiology Department, Hospital | 1 | 2020 | 805 | 0.12 | Why? |
| Neoplasm Staging | 1 | 2019 | 1999 | 0.11 | Why? |
| Nomograms | 1 | 2018 | 790 | 0.11 | Why? |
| Swine | 2 | 2018 | 3352 | 0.11 | Why? |
| Combined Modality Therapy | 2 | 2018 | 3395 | 0.11 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Humans | 42 | 2021 | 930598 | 0.11 | Why? |
| Animals | 8 | 2019 | 78931 | 0.11 | Why? |
| Retrospective Studies | 12 | 2021 | 105322 | 0.11 | Why? |
| Cell Line, Tumor | 2 | 2017 | 3608 | 0.11 | Why? |
| Diagnostic Imaging | 1 | 2019 | 1044 | 0.11 | Why? |
| Japan | 2 | 2021 | 6653 | 0.10 | Why? |
| Neoplasms | 2 | 2018 | 17251 | 0.10 | Why? |
| Temperature | 2 | 2017 | 2305 | 0.10 | Why? |
| Male | 28 | 2021 | 367725 | 0.10 | Why? |
| Sensitivity and Specificity | 5 | 2020 | 22971 | 0.09 | Why? |
| Biopsy | 3 | 2018 | 2811 | 0.09 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.09 | Why? |
| Middle Aged | 22 | 2021 | 270681 | 0.09 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Radiotherapy, Intensity-Modulated | 1 | 2007 | 148 | 0.08 | Why? |
| False Negative Reactions | 3 | 2018 | 1785 | 0.08 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.08 | Why? |
| Survival Rate | 2 | 2018 | 9206 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.07 | Why? |
| China | 3 | 2021 | 50654 | 0.07 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.07 | Why? |
| Prospective Studies | 9 | 2019 | 43301 | 0.07 | Why? |
| Liver | 1 | 2018 | 4007 | 0.07 | Why? |
| Treatment Outcome | 4 | 2019 | 51732 | 0.07 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.06 | Why? |
| Aged | 19 | 2020 | 215776 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Contrast Media | 2 | 2018 | 1011 | 0.06 | Why? |
| Female | 10 | 2021 | 380317 | 0.06 | Why? |
| Medical Oncology | 1 | 2018 | 3826 | 0.06 | Why? |
| Personal Protective Equipment | 3 | 2020 | 15978 | 0.05 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.05 | Why? |
| Reproducibility of Results | 3 | 2018 | 11304 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.05 | Why? |
| Administration, Intravesical | 1 | 2018 | 94 | 0.05 | Why? |
| Cystoscopy | 1 | 2018 | 54 | 0.05 | Why? |
| Osteomalacia | 1 | 2017 | 5 | 0.05 | Why? |
| Mice | 2 | 2016 | 21357 | 0.05 | Why? |
| Predictive Value of Tests | 3 | 2018 | 9537 | 0.04 | Why? |
| Ion Exchange | 1 | 2017 | 2 | 0.04 | Why? |
| Iodobenzenes | 1 | 2017 | 3 | 0.04 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Polyvinyl Alcohol | 1 | 2017 | 9 | 0.04 | Why? |
| Paraneoplastic Syndromes | 1 | 2017 | 28 | 0.04 | Why? |
| Benzaldehydes | 1 | 2017 | 27 | 0.04 | Why? |
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2017 | 75 | 0.04 | Why? |
| Calcitriol | 1 | 2017 | 84 | 0.04 | Why? |
| Device Approval | 1 | 2018 | 93 | 0.04 | Why? |
| Phosphates | 1 | 2017 | 135 | 0.04 | Why? |
| Fibroblast Growth Factors | 1 | 2017 | 119 | 0.04 | Why? |
| Equipment Safety | 1 | 2018 | 167 | 0.04 | Why? |
| Neoplasm Invasiveness | 1 | 2018 | 582 | 0.04 | Why? |
| Investments | 1 | 2018 | 166 | 0.04 | Why? |
| Surface Properties | 1 | 2017 | 448 | 0.04 | Why? |
| Optical Imaging | 1 | 2017 | 197 | 0.04 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.04 | Why? |
| Imaging, Three-Dimensional | 1 | 2020 | 680 | 0.04 | Why? |
| Delayed-Action Preparations | 1 | 2017 | 291 | 0.04 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Incidental Findings | 1 | 2018 | 487 | 0.03 | Why? |
| Adult | 6 | 2021 | 244371 | 0.03 | Why? |
| Awareness | 1 | 2018 | 529 | 0.03 | Why? |
| Postpartum Period | 1 | 2020 | 936 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 869 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Radiography | 1 | 2020 | 1576 | 0.03 | Why? |
| Lung Neoplasms | 1 | 2009 | 3228 | 0.03 | Why? |
| Positron-Emission Tomography | 1 | 2017 | 802 | 0.03 | Why? |
| Particle Size | 1 | 2017 | 1052 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.03 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2017 | 665 | 0.03 | Why? |
| Personnel Staffing and Scheduling | 1 | 2020 | 1578 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.02 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.02 | Why? |
| Patient Selection | 2 | 2018 | 4560 | 0.02 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| National Cancer Institute (U.S.) | 1 | 2007 | 155 | 0.02 | Why? |
| Early Detection of Cancer | 1 | 2018 | 1956 | 0.02 | Why? |
| Italy | 2 | 2021 | 38444 | 0.02 | Why? |
| Neoplasm Metastasis | 1 | 2009 | 682 | 0.02 | Why? |
| Radiotherapy Dosage | 1 | 2007 | 428 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2018 | 3444 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Prognosis | 2 | 2019 | 32490 | 0.02 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.02 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2016 | 7220 | 0.01 | Why? |
| Software | 1 | 2011 | 2501 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| ROC Curve | 1 | 2011 | 6024 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| United States | 2 | 2018 | 46150 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2007 | 43792 | 0.00 | Why? |